Graf Akcie DRIO (DarioHealth Corp). Diskuze k akciím DRIO. Aktuální informace DRIO.

Základní informace o společnosti DarioHealth Corp (Akcie DRIO)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 207.19M
Hodnota podniku (EV) N/A
Tržby 12.978M
EBITDA N/A
Zisk -50.91
Růst v tržbách Q/Q 194.40 %
Růst v tržbách Y/Y 82.28 %
P/E (Cena vůči ziskům) 0.00
Forward P/E -0.32
EV/Sales 11.08
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 15.96
P/FCF N/A
Price/Book 7.36
Účetní hodnota na akcii 2.18
Hotovost na akcii 2.22
FCF vůči ceně -16.20 %
Počet zaměstnanců 133
Tržba na zaměstnance 97.579k
Profit margin -388.66 %
Operating margin -369.83 %
Gross margin 33.17 %
EBIT margin -372.00 %
EBITDA margin -235.18 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 45.59 %
EPS - Očekávaný růst příští rok 21.13 %
Return on assets -58.22 %
Return on equity -65.78 %
ROIC -98.19 %
ROCE -40.83 %
Dluhy/Equity 0.26
Čistý dluh/EBITDA 4.92
Current ratio 5.62
Quick Ratio 5.26
Volatilita 6.33
Beta 1.70
RSI 66.24
Cílová cena analytiků 16
Známka akcie (dle analytiků) 1.00
Insider ownership 12.40 %
Institutional ownership 35.50 %
Počet akcií 16.509M
Procento shortovaných akcií 6.04 %
Short ratio 5.64 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2013
Země United States

Finanční výsledky akcie DRIO

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$7.559$7.394$5.17$2.803$0.823$0.051
Cost Of Goods Sold$4.962$5.629$3.859$3.633$1.678$2.763
Gross Profit$2.597$1.765$1.311$-0.83$-0.855$-2.712
Research And Development Expenses$3.692$3.676$3.297$2.154$2.565$3.943
SG&A Expenses$16.61$15.777$12.433$8.117$4.278$4.703
Other Operating Income Or Expenses------
Operating Expenses$25.264$25.082$19.589$13.904$8.521$11.409
Operating Income$-17.705$-17.688$-14.419$-11.101$-7.698$-11.358
Total Non-Operating Income/Expense$-0.031$-0.115$-1.324$0.214$0.556$-1.519
Pre-Tax Income$-17.736$-17.803$-15.743$-10.887$-7.142$-12.877
Income Taxes------
Income After Taxes$-17.736$-17.803$-15.743$-10.887$-7.142$-12.877
Other Income------
Income From Continuous Operations$-17.736$-17.803$-15.743$-10.887$-7.142$-12.877
Income From Discontinued Operations------
Net Income$-20.891$-18.296$-15.998$-11.607$-7.296$-16.055
EBITDA$-17.522$-17.481$-14.224$-10.714$-7.363$-10.809
EBIT$-17.705$-17.688$-14.419$-11.101$-7.698$-11.358
Basic Shares Outstanding210000
Shares Outstanding210000
Basic EPS$-8.00$-15.63$-32.80$-41.80$-76.80$-665.47
EPS - Earnings Per Share$-8.00$-15.63$-32.80$-41.80$-76.80$-665.47
# 2020 2019 2018 2017 2016 2015
Current Ratio4.39442.53722.00531.00382.53671.2723
Long-term Debt / Capital------
Debt/Equity Ratio------
Gross Margin34.356423.870725.3578-29.6111-103.8882-5317.647
Operating Margin-234.2241-239.221-278.8975-396.04-935.3584-22270.59
EBIT Margin-234.2241-239.221-278.8975-396.04-935.3584-22270.59
EBITDA Margin-231.8031-236.4214-275.1257-382.2333-894.6537-21194.12
Pre-Tax Profit Margin-234.6342-240.7763-304.5068-388.4053-867.8007-25249.02
Net Profit Margin-276.3726-247.4439-309.4391-414.0921-886.5128-31480.39
Asset Turnover0.30770.52480.74310.72390.16210.0166
Inventory Turnover Ratio3.50924.08793.25934.09122.79211.8077
Receiveable Turnover8.050113.49275.83523.83970.88020.1783
Days Sales In Receivables45.341327.051762.551395.0589414.67192046.863
ROE - Return On Equity-93.8711-199.4733-399.467166.4424452.0259243.1918
Return On Tangible Equity-93.8711-199.4734-399.4672166.4424-919.1764507.3681
ROA - Return On Assets-72.1885-126.361-226.2901-281.1725-140.6736-417.9487
ROI - Return On Investment-93.8711-199.4734-399.4672166.4424-919.1763507.368
Book Value Per Share8.45124.87245.6004-22.89875.3365-56.2404
Operating Cash Flow Per Share2.858912.260610.149733.935289.5072390.7793
Free Cash Flow Per Share2.876312.60512.850531.9882311.6824504.9271